Patent · US Active

PD-L1 binding fibronectin type III domains

US11447539B2 · kind B2 · utility

0Cited by
50References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2020
Grant dateSep 20, 2022
Priority date
Expiry dateFeb 26, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/61
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

FN3 domains that specifically bind to PD-L1, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.